“On behalf of the ASC Board of Directors, I am very pleased to announce and welcome the new Chief Executive Officer of the Alzheimer Society of Canada, Ronan Ryan,” said Kevin O’Shea, Chair of the Board of Directors. “The Board's selection of Ronan as CEO comes after extensive consultation and a comprehensive search process throughout the country. This included consultative meetings and conversations with Board members, partners, ASC staff members, and the Advisory Group of people living with dementia.
“I am confident that Ronan's experience and approach is the perfect fit for our organization and that he will help us achieve the ambitious vision and targets we are setting to better serve people living with dementia in our country.”
Ronan previously served as the Chief of Commercial Operations at the Canadian Red Cross, where he led a team of awarded-winning fundraisers and marketers raising $1 billion in five years. He transformed the organization’s fundraising operating model, led a powerful digital renewal and developed the Canadian Red Cross’s first Transformational Giving campaign. A particular highlight under his leadership was the campaign to support those affected by the wildfires in Fort McMurray, a multi-channel marketing and philanthropy campaign that raised $329 million and touched Canadians from coast to coast to coast.
Ronan serves as Vice-chair of the board of Imagine Canada, and has served on various advisory bodies such as the Canadian Marketing Association’s Not-for-profit Council and the Advisory Board of the Masters in Management Analytics Program at Queens University. He lives outside of Toronto with his wife and three children.
Ronan joined the team in December, and is excited to forge ahead: “In common with so many Canadians, dementia has touched my family. We face a doubling of the disease over the next decade and there are significant challenges ahead. I am ready and honoured to lead the team at the Alzheimer Society of Canada as we fight for the rights and interests of those impacted by Alzheimer’s disease and other dementias.”
Email: [email protected]